780 related articles for article (PubMed ID: 28303906)
1. Advances and challenges in targeting FGFR signalling in cancer.
Babina IS; Turner NC
Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
[TBL] [Abstract][Full Text] [Related]
2. Recent developments and advances of FGFR as a potential target in cancer.
Xue WJ; Li MT; Chen L; Sun LP; Li YY
Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
[TBL] [Abstract][Full Text] [Related]
3. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
4. Clinical complexity of utilizing FGFR inhibitors in cancer therapeutics.
Chandana SR; Babiker HM; Mahadevan D
Expert Opin Investig Drugs; 2020 Dec; 29(12):1413-1429. PubMed ID: 33074030
[TBL] [Abstract][Full Text] [Related]
5. Future applications of FGF/FGFR inhibitors in cancer.
Ghedini GC; Ronca R; Presta M; Giacomini A
Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
[TBL] [Abstract][Full Text] [Related]
6. The FGF/FGFR signalling mediated anti-cancer drug resistance and therapeutic intervention.
Mahapatra S; Jonniya NA; Koirala S; Ursal KD; Kar P
J Biomol Struct Dyn; 2023; 41(22):13509-13533. PubMed ID: 36995019
[TBL] [Abstract][Full Text] [Related]
7. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancer.
Piasecka D; Braun M; Kitowska K; Mieczkowski K; Kordek R; Sadej R; Romanska H
J Exp Clin Cancer Res; 2019 May; 38(1):230. PubMed ID: 31142340
[TBL] [Abstract][Full Text] [Related]
8. FGFR-TKI resistance in cancer: current status and perspectives.
Yue S; Li Y; Chen X; Wang J; Li M; Chen Y; Wu D
J Hematol Oncol; 2021 Feb; 14(1):23. PubMed ID: 33568192
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor receptor signalling dysregulation and targeting in breast cancer.
Francavilla C; O'Brien CS
Open Biol; 2022 Feb; 12(2):210373. PubMed ID: 35193394
[TBL] [Abstract][Full Text] [Related]
10. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder.
Roskoski R
Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593
[TBL] [Abstract][Full Text] [Related]
11. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
[TBL] [Abstract][Full Text] [Related]
12. FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention.
De Luca A; Esposito Abate R; Rachiglio AM; Maiello MR; Esposito C; Schettino C; Izzo F; Nasti G; Normanno N
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962091
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer.
Yashiro M; Matsuoka T
World J Gastroenterol; 2016 Feb; 22(8):2415-23. PubMed ID: 26937130
[TBL] [Abstract][Full Text] [Related]
15. Selective FGFR/FGF pathway inhibitors: inhibition strategies, clinical activities, resistance mutations, and future directions.
Repetto M; Crimini E; Giugliano F; Morganti S; Belli C; Curigliano G
Expert Rev Clin Pharmacol; 2021 Oct; 14(10):1233-1252. PubMed ID: 34591728
[No Abstract] [Full Text] [Related]
16. Deciphering role of FGFR signalling pathway in pancreatic cancer.
Kang X; Lin Z; Xu M; Pan J; Wang ZW
Cell Prolif; 2019 May; 52(3):e12605. PubMed ID: 30945363
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment.
Liu G; Chen T; Ding Z; Wang Y; Wei Y; Wei X
Cell Prolif; 2021 Apr; 54(4):e13009. PubMed ID: 33655556
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors.
Dai S; Zhou Z; Chen Z; Xu G; Chen Y
Cells; 2019 Jun; 8(6):. PubMed ID: 31216761
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor fusions in cancer: opportunities and challenges.
Chen L; Zhang Y; Yin L; Cai B; Huang P; Li X; Liang G
J Exp Clin Cancer Res; 2021 Nov; 40(1):345. PubMed ID: 34732230
[TBL] [Abstract][Full Text] [Related]
20. Role of fibroblast growth factor receptor 4 in cancer.
Tang S; Hao Y; Yuan Y; Liu R; Chen Q
Cancer Sci; 2018 Oct; 109(10):3024-3031. PubMed ID: 30070748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
